Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | 12-2016 | |
| Cash Flows From Operating Activities | ||
| Net Income | -20,542 | -9,430 |
| Depreciation Amortization | 129 | 6 |
| Accounts payable and accrued liabilities | 415 | N/A |
| Other Working Capital | 1,629 | 1,590 |
| Other Operating Activity | 9,781 | 1,314 |
| Operating Cash Flow | $-8,588 | $-6,520 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,497 | -130 |
| Other Investing Activity | -135 | -30 |
| Investing Cash Flow | $-1,632 | $-160 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 69,488 | 10,710 |
| Financing Cash Flow | $69,488 | $10,710 |
| Beginning Cash Position | 4,513 | 500 |
| End Cash Position | 63,781 | 4,510 |
| Net Cash Flow | $59,268 | $4,010 |
| Free Cash Flow | ||
| Operating Cash Flow | -8,588 | -6,520 |
| Capital Expenditure | -1,497 | N/A |
| Free Cash Flow | -10,085 | -6,520 |